Global Point of Care Molecular Diagnostics Technology Production, Demand and Key Producers, 2022-2028
This report studies the global Point of Care Molecular Diagnostics Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point of Care Molecular Diagnostics Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point of Care Molecular Diagnostics Technology that contribute to its increasing demand across many markets.
The global Point of Care Molecular Diagnostics Technology market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Point of Care Molecular Diagnostics Technology total market, 2017-2028, (USD Million)
Global Point of Care Molecular Diagnostics Technology total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Point of Care Molecular Diagnostics Technology total market, key domestic companies and share, (USD Million)
Global Point of Care Molecular Diagnostics Technology revenue by player and market share 2017-2022, (USD Million)
Global Point of Care Molecular Diagnostics Technology total market by Type, CAGR, 2017-2028, (USD Million)
Global Point of Care Molecular Diagnostics Technology total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Point of Care Molecular Diagnostics Technology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioM?rieux and Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point of Care Molecular Diagnostics Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Point of Care Molecular Diagnostics Technology Market, By Region:
1. How big is the global Point of Care Molecular Diagnostics Technology market?
2. What is the demand of the global Point of Care Molecular Diagnostics Technology market?
3. What is the year over year growth of the global Point of Care Molecular Diagnostics Technology market?
4. What is the total value of the global Point of Care Molecular Diagnostics Technology market?
5. Who are the major players in the global Point of Care Molecular Diagnostics Technology market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Point of Care Molecular Diagnostics Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point of Care Molecular Diagnostics Technology that contribute to its increasing demand across many markets.
The global Point of Care Molecular Diagnostics Technology market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Point of Care Molecular Diagnostics Technology total market, 2017-2028, (USD Million)
Global Point of Care Molecular Diagnostics Technology total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Point of Care Molecular Diagnostics Technology total market, key domestic companies and share, (USD Million)
Global Point of Care Molecular Diagnostics Technology revenue by player and market share 2017-2022, (USD Million)
Global Point of Care Molecular Diagnostics Technology total market by Type, CAGR, 2017-2028, (USD Million)
Global Point of Care Molecular Diagnostics Technology total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Point of Care Molecular Diagnostics Technology market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Accelerate Diagnostics, Ador Diagnostics, Beckman Coulter, Becton, Dickinson and Company, Binx Health, Biocartis, bioM?rieux and Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point of Care Molecular Diagnostics Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Point of Care Molecular Diagnostics Technology Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Polymerase Chain Reaction
- In Situ Hybridization
- Gene Chips
- Next Generation Sequencing
- Hospitals and Clinics
- Independent Clinical Laboratories
- Abbott
- Accelerate Diagnostics
- Ador Diagnostics
- Beckman Coulter
- Becton, Dickinson and Company
- Binx Health
- Biocartis
- bioM?rieux
- Bio-Rad Laboratories
- Bosch Healthcare Solutions
- Curetis
- Eurofins Scientific
- Genetic Signatures
- Grifols
- Hibergene Diagnostics
- Lumos Diagnostics
- Roche
- Siemens
- Thermo Fisher Scientific
1. How big is the global Point of Care Molecular Diagnostics Technology market?
2. What is the demand of the global Point of Care Molecular Diagnostics Technology market?
3. What is the year over year growth of the global Point of Care Molecular Diagnostics Technology market?
4. What is the total value of the global Point of Care Molecular Diagnostics Technology market?
5. Who are the major players in the global Point of Care Molecular Diagnostics Technology market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Point of Care Molecular Diagnostics Technology Introduction
1.2 World Point of Care Molecular Diagnostics Technology Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Point of Care Molecular Diagnostics Technology Total Market by Region
1.3.1 World Point of Care Molecular Diagnostics Technology Market Size by Region (2017-2028)
1.3.2 United States Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.3 China Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.4 Europe Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.5 Japan Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.6 South Korea Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.7 ASEAN Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.8 India Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point of Care Molecular Diagnostics Technology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point of Care Molecular Diagnostics Technology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD POINT OF CARE MOLECULAR DIAGNOSTICS TECHNOLOGY COMPANIES COMPETITIVE ANALYSIS
2.1 World Point of Care Molecular Diagnostics Technology Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Point of Care Molecular Diagnostics Technology Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Point of Care Molecular Diagnostics Technology in 2021
2.2.3 Global Concentration Ratios (CR8) for Point of Care Molecular Diagnostics Technology in 2021
2.3 Point of Care Molecular Diagnostics Technology Company Evaluation Quadrant
2.4 Point of Care Molecular Diagnostics Technology Market: Overall Company Footprint Analysis
2.4.1 Point of Care Molecular Diagnostics Technology Market: Region Footprint
2.4.2 Point of Care Molecular Diagnostics Technology Market: Company Product Type Footprint
2.4.3 Point of Care Molecular Diagnostics Technology Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Point of Care Molecular Diagnostics Technology Market Comparison
3.1.1 United States VS China: Point of Care Molecular Diagnostics Technology Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Point of Care Molecular Diagnostics Technology Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Point of Care Molecular Diagnostics Technology Major Players and Market Share, 2017-2022
3.2.1 Major Players of Point of Care Molecular Diagnostics Technology in United States, Headquarters (States, Country)
3.2.2 United States Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022)
3.3 China Point of Care Molecular Diagnostics Technology Major Players and Market Share, 2017-2022
3.3.1 Major Players of Point of Care Molecular Diagnostics Technology in China, Headquarters (Province, Country)
3.3.2 China Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Point of Care Molecular Diagnostics Technology Major Players and Market Share, 2017-2022
3.4.1 Major Players of Point of Care Molecular Diagnostics Technology in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Point of Care Molecular Diagnostics Technology Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Polymerase Chain Reaction
4.2.2 In Situ Hybridization
4.2.3 Gene Chips
4.2.4 Next Generation Sequencing
4.3 Market Segment by Type
4.3.1 World Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
4.3.2 World Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
4.3.3 World Point of Care Molecular Diagnostics Technology Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Point of Care Molecular Diagnostics Technology Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals and Clinics
5.2.2 Independent Clinical Laboratories
5.3 Market Segment by Application
5.3.1 World Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
5.3.2 World Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
5.3.3 World Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Point of Care Molecular Diagnostics Technology Product and Services
6.1.4 Abbott Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 Accelerate Diagnostics
6.2.1 Accelerate Diagnostics Details
6.2.2 Accelerate Diagnostics Major Business
6.2.3 Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.2.4 Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Accelerate Diagnostics Recent Developments/Updates
6.2.6 Accelerate Diagnostics Competitive Strengths & Weaknesses
6.3 Ador Diagnostics
6.3.1 Ador Diagnostics Details
6.3.2 Ador Diagnostics Major Business
6.3.3 Ador Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.3.4 Ador Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Ador Diagnostics Recent Developments/Updates
6.3.6 Ador Diagnostics Competitive Strengths & Weaknesses
6.4 Beckman Coulter
6.4.1 Beckman Coulter Details
6.4.2 Beckman Coulter Major Business
6.4.3 Beckman Coulter Point of Care Molecular Diagnostics Technology Product and Services
6.4.4 Beckman Coulter Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Beckman Coulter Recent Developments/Updates
6.4.6 Beckman Coulter Competitive Strengths & Weaknesses
6.5 Becton, Dickinson and Company
6.5.1 Becton, Dickinson and Company Details
6.5.2 Becton, Dickinson and Company Major Business
6.5.3 Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Product and Services
6.5.4 Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Becton, Dickinson and Company Recent Developments/Updates
6.5.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
6.6 Binx Health
6.6.1 Binx Health Details
6.6.2 Binx Health Major Business
6.6.3 Binx Health Point of Care Molecular Diagnostics Technology Product and Services
6.6.4 Binx Health Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Binx Health Recent Developments/Updates
6.6.6 Binx Health Competitive Strengths & Weaknesses
6.7 Biocartis
6.7.1 Biocartis Details
6.7.2 Biocartis Major Business
6.7.3 Biocartis Point of Care Molecular Diagnostics Technology Product and Services
6.7.4 Biocartis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Biocartis Recent Developments/Updates
6.7.6 Biocartis Competitive Strengths & Weaknesses
6.8 bioM?rieux
6.8.1 bioM?rieux Details
6.8.2 bioM?rieux Major Business
6.8.3 bioM?rieux Point of Care Molecular Diagnostics Technology Product and Services
6.8.4 bioM?rieux Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 bioM?rieux Recent Developments/Updates
6.8.6 bioM?rieux Competitive Strengths & Weaknesses
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Details
6.9.2 Bio-Rad Laboratories Major Business
6.9.3 Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Product and Services
6.9.4 Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Bio-Rad Laboratories Recent Developments/Updates
6.9.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
6.10 Bosch Healthcare Solutions
6.10.1 Bosch Healthcare Solutions Details
6.10.2 Bosch Healthcare Solutions Major Business
6.10.3 Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Product and Services
6.10.4 Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Bosch Healthcare Solutions Recent Developments/Updates
6.10.6 Bosch Healthcare Solutions Competitive Strengths & Weaknesses
6.11 Curetis
6.11.1 Curetis Details
6.11.2 Curetis Major Business
6.11.3 Curetis Point of Care Molecular Diagnostics Technology Product and Services
6.11.4 Curetis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Curetis Recent Developments/Updates
6.11.6 Curetis Competitive Strengths & Weaknesses
6.12 Eurofins Scientific
6.12.1 Eurofins Scientific Details
6.12.2 Eurofins Scientific Major Business
6.12.3 Eurofins Scientific Point of Care Molecular Diagnostics Technology Product and Services
6.12.4 Eurofins Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Eurofins Scientific Recent Developments/Updates
6.12.6 Eurofins Scientific Competitive Strengths & Weaknesses
6.13 Genetic Signatures
6.13.1 Genetic Signatures Details
6.13.2 Genetic Signatures Major Business
6.13.3 Genetic Signatures Point of Care Molecular Diagnostics Technology Product and Services
6.13.4 Genetic Signatures Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Genetic Signatures Recent Developments/Updates
6.13.6 Genetic Signatures Competitive Strengths & Weaknesses
6.14 Grifols
6.14.1 Grifols Details
6.14.2 Grifols Major Business
6.14.3 Grifols Point of Care Molecular Diagnostics Technology Product and Services
6.14.4 Grifols Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Grifols Recent Developments/Updates
6.14.6 Grifols Competitive Strengths & Weaknesses
6.15 Hibergene Diagnostics
6.15.1 Hibergene Diagnostics Details
6.15.2 Hibergene Diagnostics Major Business
6.15.3 Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.15.4 Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Hibergene Diagnostics Recent Developments/Updates
6.15.6 Hibergene Diagnostics Competitive Strengths & Weaknesses
6.16 Lumos Diagnostics
6.16.1 Lumos Diagnostics Details
6.16.2 Lumos Diagnostics Major Business
6.16.3 Lumos Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.16.4 Lumos Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Lumos Diagnostics Recent Developments/Updates
6.16.6 Lumos Diagnostics Competitive Strengths & Weaknesses
6.17 Roche
6.17.1 Roche Details
6.17.2 Roche Major Business
6.17.3 Roche Point of Care Molecular Diagnostics Technology Product and Services
6.17.4 Roche Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Roche Recent Developments/Updates
6.17.6 Roche Competitive Strengths & Weaknesses
6.18 Siemens
6.18.1 Siemens Details
6.18.2 Siemens Major Business
6.18.3 Siemens Point of Care Molecular Diagnostics Technology Product and Services
6.18.4 Siemens Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Siemens Recent Developments/Updates
6.18.6 Siemens Competitive Strengths & Weaknesses
6.19 Thermo Fisher Scientific
6.19.1 Thermo Fisher Scientific Details
6.19.2 Thermo Fisher Scientific Major Business
6.19.3 Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Product and Services
6.19.4 Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Thermo Fisher Scientific Recent Developments/Updates
6.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Point of Care Molecular Diagnostics Technology and Key Manufacturers
7.2 Point of Care Molecular Diagnostics Technology Manufacturing Costs
7.3 Point of Care Molecular Diagnostics Technology Production Process
7.4 Point of Care Molecular Diagnostics Technology Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Point of Care Molecular Diagnostics Technology Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Point of Care Molecular Diagnostics Technology Typical Distributors
8.3 Point of Care Molecular Diagnostics Technology Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Point of Care Molecular Diagnostics Technology Introduction
1.2 World Point of Care Molecular Diagnostics Technology Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Point of Care Molecular Diagnostics Technology Total Market by Region
1.3.1 World Point of Care Molecular Diagnostics Technology Market Size by Region (2017-2028)
1.3.2 United States Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.3 China Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.4 Europe Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.5 Japan Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.6 South Korea Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.7 ASEAN Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.3.8 India Point of Care Molecular Diagnostics Technology Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point of Care Molecular Diagnostics Technology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point of Care Molecular Diagnostics Technology Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD POINT OF CARE MOLECULAR DIAGNOSTICS TECHNOLOGY COMPANIES COMPETITIVE ANALYSIS
2.1 World Point of Care Molecular Diagnostics Technology Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Point of Care Molecular Diagnostics Technology Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Point of Care Molecular Diagnostics Technology in 2021
2.2.3 Global Concentration Ratios (CR8) for Point of Care Molecular Diagnostics Technology in 2021
2.3 Point of Care Molecular Diagnostics Technology Company Evaluation Quadrant
2.4 Point of Care Molecular Diagnostics Technology Market: Overall Company Footprint Analysis
2.4.1 Point of Care Molecular Diagnostics Technology Market: Region Footprint
2.4.2 Point of Care Molecular Diagnostics Technology Market: Company Product Type Footprint
2.4.3 Point of Care Molecular Diagnostics Technology Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Point of Care Molecular Diagnostics Technology Market Comparison
3.1.1 United States VS China: Point of Care Molecular Diagnostics Technology Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Point of Care Molecular Diagnostics Technology Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Point of Care Molecular Diagnostics Technology Major Players and Market Share, 2017-2022
3.2.1 Major Players of Point of Care Molecular Diagnostics Technology in United States, Headquarters (States, Country)
3.2.2 United States Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022)
3.3 China Point of Care Molecular Diagnostics Technology Major Players and Market Share, 2017-2022
3.3.1 Major Players of Point of Care Molecular Diagnostics Technology in China, Headquarters (Province, Country)
3.3.2 China Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Point of Care Molecular Diagnostics Technology Major Players and Market Share, 2017-2022
3.4.1 Major Players of Point of Care Molecular Diagnostics Technology in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Point of Care Molecular Diagnostics Technology Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Polymerase Chain Reaction
4.2.2 In Situ Hybridization
4.2.3 Gene Chips
4.2.4 Next Generation Sequencing
4.3 Market Segment by Type
4.3.1 World Point of Care Molecular Diagnostics Technology Market Size by Type (2017-2022)
4.3.2 World Point of Care Molecular Diagnostics Technology Market Size by Type (2023-2028)
4.3.3 World Point of Care Molecular Diagnostics Technology Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Point of Care Molecular Diagnostics Technology Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospitals and Clinics
5.2.2 Independent Clinical Laboratories
5.3 Market Segment by Application
5.3.1 World Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2022)
5.3.2 World Point of Care Molecular Diagnostics Technology Market Size by Application (2023-2028)
5.3.3 World Point of Care Molecular Diagnostics Technology Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Point of Care Molecular Diagnostics Technology Product and Services
6.1.4 Abbott Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 Accelerate Diagnostics
6.2.1 Accelerate Diagnostics Details
6.2.2 Accelerate Diagnostics Major Business
6.2.3 Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.2.4 Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Accelerate Diagnostics Recent Developments/Updates
6.2.6 Accelerate Diagnostics Competitive Strengths & Weaknesses
6.3 Ador Diagnostics
6.3.1 Ador Diagnostics Details
6.3.2 Ador Diagnostics Major Business
6.3.3 Ador Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.3.4 Ador Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Ador Diagnostics Recent Developments/Updates
6.3.6 Ador Diagnostics Competitive Strengths & Weaknesses
6.4 Beckman Coulter
6.4.1 Beckman Coulter Details
6.4.2 Beckman Coulter Major Business
6.4.3 Beckman Coulter Point of Care Molecular Diagnostics Technology Product and Services
6.4.4 Beckman Coulter Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Beckman Coulter Recent Developments/Updates
6.4.6 Beckman Coulter Competitive Strengths & Weaknesses
6.5 Becton, Dickinson and Company
6.5.1 Becton, Dickinson and Company Details
6.5.2 Becton, Dickinson and Company Major Business
6.5.3 Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Product and Services
6.5.4 Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Becton, Dickinson and Company Recent Developments/Updates
6.5.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
6.6 Binx Health
6.6.1 Binx Health Details
6.6.2 Binx Health Major Business
6.6.3 Binx Health Point of Care Molecular Diagnostics Technology Product and Services
6.6.4 Binx Health Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Binx Health Recent Developments/Updates
6.6.6 Binx Health Competitive Strengths & Weaknesses
6.7 Biocartis
6.7.1 Biocartis Details
6.7.2 Biocartis Major Business
6.7.3 Biocartis Point of Care Molecular Diagnostics Technology Product and Services
6.7.4 Biocartis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Biocartis Recent Developments/Updates
6.7.6 Biocartis Competitive Strengths & Weaknesses
6.8 bioM?rieux
6.8.1 bioM?rieux Details
6.8.2 bioM?rieux Major Business
6.8.3 bioM?rieux Point of Care Molecular Diagnostics Technology Product and Services
6.8.4 bioM?rieux Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 bioM?rieux Recent Developments/Updates
6.8.6 bioM?rieux Competitive Strengths & Weaknesses
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Details
6.9.2 Bio-Rad Laboratories Major Business
6.9.3 Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Product and Services
6.9.4 Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Bio-Rad Laboratories Recent Developments/Updates
6.9.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
6.10 Bosch Healthcare Solutions
6.10.1 Bosch Healthcare Solutions Details
6.10.2 Bosch Healthcare Solutions Major Business
6.10.3 Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Product and Services
6.10.4 Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Bosch Healthcare Solutions Recent Developments/Updates
6.10.6 Bosch Healthcare Solutions Competitive Strengths & Weaknesses
6.11 Curetis
6.11.1 Curetis Details
6.11.2 Curetis Major Business
6.11.3 Curetis Point of Care Molecular Diagnostics Technology Product and Services
6.11.4 Curetis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Curetis Recent Developments/Updates
6.11.6 Curetis Competitive Strengths & Weaknesses
6.12 Eurofins Scientific
6.12.1 Eurofins Scientific Details
6.12.2 Eurofins Scientific Major Business
6.12.3 Eurofins Scientific Point of Care Molecular Diagnostics Technology Product and Services
6.12.4 Eurofins Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Eurofins Scientific Recent Developments/Updates
6.12.6 Eurofins Scientific Competitive Strengths & Weaknesses
6.13 Genetic Signatures
6.13.1 Genetic Signatures Details
6.13.2 Genetic Signatures Major Business
6.13.3 Genetic Signatures Point of Care Molecular Diagnostics Technology Product and Services
6.13.4 Genetic Signatures Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Genetic Signatures Recent Developments/Updates
6.13.6 Genetic Signatures Competitive Strengths & Weaknesses
6.14 Grifols
6.14.1 Grifols Details
6.14.2 Grifols Major Business
6.14.3 Grifols Point of Care Molecular Diagnostics Technology Product and Services
6.14.4 Grifols Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Grifols Recent Developments/Updates
6.14.6 Grifols Competitive Strengths & Weaknesses
6.15 Hibergene Diagnostics
6.15.1 Hibergene Diagnostics Details
6.15.2 Hibergene Diagnostics Major Business
6.15.3 Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.15.4 Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Hibergene Diagnostics Recent Developments/Updates
6.15.6 Hibergene Diagnostics Competitive Strengths & Weaknesses
6.16 Lumos Diagnostics
6.16.1 Lumos Diagnostics Details
6.16.2 Lumos Diagnostics Major Business
6.16.3 Lumos Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
6.16.4 Lumos Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Lumos Diagnostics Recent Developments/Updates
6.16.6 Lumos Diagnostics Competitive Strengths & Weaknesses
6.17 Roche
6.17.1 Roche Details
6.17.2 Roche Major Business
6.17.3 Roche Point of Care Molecular Diagnostics Technology Product and Services
6.17.4 Roche Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Roche Recent Developments/Updates
6.17.6 Roche Competitive Strengths & Weaknesses
6.18 Siemens
6.18.1 Siemens Details
6.18.2 Siemens Major Business
6.18.3 Siemens Point of Care Molecular Diagnostics Technology Product and Services
6.18.4 Siemens Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Siemens Recent Developments/Updates
6.18.6 Siemens Competitive Strengths & Weaknesses
6.19 Thermo Fisher Scientific
6.19.1 Thermo Fisher Scientific Details
6.19.2 Thermo Fisher Scientific Major Business
6.19.3 Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Product and Services
6.19.4 Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Thermo Fisher Scientific Recent Developments/Updates
6.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Point of Care Molecular Diagnostics Technology and Key Manufacturers
7.2 Point of Care Molecular Diagnostics Technology Manufacturing Costs
7.3 Point of Care Molecular Diagnostics Technology Production Process
7.4 Point of Care Molecular Diagnostics Technology Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Point of Care Molecular Diagnostics Technology Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Point of Care Molecular Diagnostics Technology Typical Distributors
8.3 Point of Care Molecular Diagnostics Technology Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Point of Care Molecular Diagnostics Technology Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Point of Care Molecular Diagnostics Technology Market Size by Region (2017-2022) & (USD Million)
Table 3. World Point of Care Molecular Diagnostics Technology Market Size by Region (2023-2028) & (USD Million)
Table 4. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Region (2017-2022)
Table 5. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Point of Care Molecular Diagnostics Technology Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Point of Care Molecular Diagnostics Technology Players in 2021
Table 9. World Point of Care Molecular Diagnostics Technology Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Point of Care Molecular Diagnostics Technology Company Evaluation Quadrant
Table 11. Head Office of Key Point of Care Molecular Diagnostics Technology Player
Table 12. Point of Care Molecular Diagnostics Technology Market: Company Product Type Footprint
Table 13. Point of Care Molecular Diagnostics Technology Market: Company Product Application Footprint
Table 14. Point of Care Molecular Diagnostics Technology Mergers & Acquisitions Activity
Table 15. United States VS China Point of Care Molecular Diagnostics Technology Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Point of Care Molecular Diagnostics Technology in United States, Headquarters (States, Country)
Table 17. United States Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Point of Care Molecular Diagnostics Technology Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Point of Care Molecular Diagnostics Technology in China, Company Headquarters (Province, Country)
Table 20. China Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Point of Care Molecular Diagnostics Technology Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Point of Care Molecular Diagnostics Technology in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Point of Care Molecular Diagnostics Technology Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Point of Care Molecular Diagnostics Technology Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Point of Care Molecular Diagnostics Technology Revenue by Type (2017-2022) & (USD Million)
Table 27. World Point of Care Molecular Diagnostics Technology Revenue by Type (2023-2028) & (USD Million)
Table 28. World Point of Care Molecular Diagnostics Technology Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Point of Care Molecular Diagnostics Technology Revenue by Application (2017-2022) & (USD Million)
Table 30. World Point of Care Molecular Diagnostics Technology Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Point of Care Molecular Diagnostics Technology Product and Services
Table 34. Abbott Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. Accelerate Diagnostics Basic Information, Manufacturing Base and Competitors
Table 38. Accelerate Diagnostics Major Business
Table 39. Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 40. Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Accelerate Diagnostics Recent Developments/Updates
Table 42. Accelerate Diagnostics Competitive Strengths & Weaknesses
Table 43. Ador Diagnostics Basic Information, Manufacturing Base and Competitors
Table 44. Ador Diagnostics Major Business
Table 45. Ador Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 46. Ador Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Ador Diagnostics Recent Developments/Updates
Table 48. Ador Diagnostics Competitive Strengths & Weaknesses
Table 49. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 50. Beckman Coulter Major Business
Table 51. Beckman Coulter Point of Care Molecular Diagnostics Technology Product and Services
Table 52. Beckman Coulter Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Beckman Coulter Recent Developments/Updates
Table 54. Beckman Coulter Competitive Strengths & Weaknesses
Table 55. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 56. Becton, Dickinson and Company Major Business
Table 57. Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Product and Services
Table 58. Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Becton, Dickinson and Company Recent Developments/Updates
Table 60. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 61. Binx Health Basic Information, Manufacturing Base and Competitors
Table 62. Binx Health Major Business
Table 63. Binx Health Point of Care Molecular Diagnostics Technology Product and Services
Table 64. Binx Health Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Binx Health Recent Developments/Updates
Table 66. Binx Health Competitive Strengths & Weaknesses
Table 67. Biocartis Basic Information, Manufacturing Base and Competitors
Table 68. Biocartis Major Business
Table 69. Biocartis Point of Care Molecular Diagnostics Technology Product and Services
Table 70. Biocartis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Biocartis Recent Developments/Updates
Table 72. Biocartis Competitive Strengths & Weaknesses
Table 73. bioM?rieux Basic Information, Manufacturing Base and Competitors
Table 74. bioM?rieux Major Business
Table 75. bioM?rieux Point of Care Molecular Diagnostics Technology Product and Services
Table 76. bioM?rieux Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. bioM?rieux Recent Developments/Updates
Table 78. bioM?rieux Competitive Strengths & Weaknesses
Table 79. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 80. Bio-Rad Laboratories Major Business
Table 81. Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Product and Services
Table 82. Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Bio-Rad Laboratories Recent Developments/Updates
Table 84. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 85. Bosch Healthcare Solutions Basic Information, Manufacturing Base and Competitors
Table 86. Bosch Healthcare Solutions Major Business
Table 87. Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Product and Services
Table 88. Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Bosch Healthcare Solutions Recent Developments/Updates
Table 90. Bosch Healthcare Solutions Competitive Strengths & Weaknesses
Table 91. Curetis Basic Information, Manufacturing Base and Competitors
Table 92. Curetis Major Business
Table 93. Curetis Point of Care Molecular Diagnostics Technology Product and Services
Table 94. Curetis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Curetis Recent Developments/Updates
Table 96. Curetis Competitive Strengths & Weaknesses
Table 97. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 98. Eurofins Scientific Major Business
Table 99. Eurofins Scientific Point of Care Molecular Diagnostics Technology Product and Services
Table 100. Eurofins Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Eurofins Scientific Recent Developments/Updates
Table 102. Eurofins Scientific Competitive Strengths & Weaknesses
Table 103. Genetic Signatures Basic Information, Manufacturing Base and Competitors
Table 104. Genetic Signatures Major Business
Table 105. Genetic Signatures Point of Care Molecular Diagnostics Technology Product and Services
Table 106. Genetic Signatures Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Genetic Signatures Recent Developments/Updates
Table 108. Genetic Signatures Competitive Strengths & Weaknesses
Table 109. Grifols Basic Information, Manufacturing Base and Competitors
Table 110. Grifols Major Business
Table 111. Grifols Point of Care Molecular Diagnostics Technology Product and Services
Table 112. Grifols Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Grifols Recent Developments/Updates
Table 114. Grifols Competitive Strengths & Weaknesses
Table 115. Hibergene Diagnostics Basic Information, Manufacturing Base and Competitors
Table 116. Hibergene Diagnostics Major Business
Table 117. Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 118. Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Hibergene Diagnostics Recent Developments/Updates
Table 120. Hibergene Diagnostics Competitive Strengths & Weaknesses
Table 121. Lumos Diagnostics Basic Information, Manufacturing Base and Competitors
Table 122. Lumos Diagnostics Major Business
Table 123. Lumos Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 124. Lumos Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Lumos Diagnostics Recent Developments/Updates
Table 126. Lumos Diagnostics Competitive Strengths & Weaknesses
Table 127. Roche Basic Information, Manufacturing Base and Competitors
Table 128. Roche Major Business
Table 129. Roche Point of Care Molecular Diagnostics Technology Product and Services
Table 130. Roche Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Roche Recent Developments/Updates
Table 132. Roche Competitive Strengths & Weaknesses
Table 133. Siemens Basic Information, Manufacturing Base and Competitors
Table 134. Siemens Major Business
Table 135. Siemens Point of Care Molecular Diagnostics Technology Product and Services
Table 136. Siemens Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Siemens Recent Developments/Updates
Table 138. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 139. Thermo Fisher Scientific Major Business
Table 140. Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Product and Services
Table 141. Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 142. Point of Care Molecular Diagnostics Technology Raw Material
Table 143. Key Manufacturers of Point of Care Molecular Diagnostics Technology Raw Materials
Table 144. Point of Care Molecular Diagnostics Technology Typical Distributors
Table 145. Point of Care Molecular Diagnostics Technology Typical Customers
Table 1. World Point of Care Molecular Diagnostics Technology Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Point of Care Molecular Diagnostics Technology Market Size by Region (2017-2022) & (USD Million)
Table 3. World Point of Care Molecular Diagnostics Technology Market Size by Region (2023-2028) & (USD Million)
Table 4. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Region (2017-2022)
Table 5. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Point of Care Molecular Diagnostics Technology Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Point of Care Molecular Diagnostics Technology Players in 2021
Table 9. World Point of Care Molecular Diagnostics Technology Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Point of Care Molecular Diagnostics Technology Company Evaluation Quadrant
Table 11. Head Office of Key Point of Care Molecular Diagnostics Technology Player
Table 12. Point of Care Molecular Diagnostics Technology Market: Company Product Type Footprint
Table 13. Point of Care Molecular Diagnostics Technology Market: Company Product Application Footprint
Table 14. Point of Care Molecular Diagnostics Technology Mergers & Acquisitions Activity
Table 15. United States VS China Point of Care Molecular Diagnostics Technology Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Point of Care Molecular Diagnostics Technology in United States, Headquarters (States, Country)
Table 17. United States Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Point of Care Molecular Diagnostics Technology Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Point of Care Molecular Diagnostics Technology in China, Company Headquarters (Province, Country)
Table 20. China Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Point of Care Molecular Diagnostics Technology Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Point of Care Molecular Diagnostics Technology in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Point of Care Molecular Diagnostics Technology Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Point of Care Molecular Diagnostics Technology Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Point of Care Molecular Diagnostics Technology Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Point of Care Molecular Diagnostics Technology Revenue by Type (2017-2022) & (USD Million)
Table 27. World Point of Care Molecular Diagnostics Technology Revenue by Type (2023-2028) & (USD Million)
Table 28. World Point of Care Molecular Diagnostics Technology Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Point of Care Molecular Diagnostics Technology Revenue by Application (2017-2022) & (USD Million)
Table 30. World Point of Care Molecular Diagnostics Technology Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Point of Care Molecular Diagnostics Technology Product and Services
Table 34. Abbott Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. Accelerate Diagnostics Basic Information, Manufacturing Base and Competitors
Table 38. Accelerate Diagnostics Major Business
Table 39. Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 40. Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Accelerate Diagnostics Recent Developments/Updates
Table 42. Accelerate Diagnostics Competitive Strengths & Weaknesses
Table 43. Ador Diagnostics Basic Information, Manufacturing Base and Competitors
Table 44. Ador Diagnostics Major Business
Table 45. Ador Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 46. Ador Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Ador Diagnostics Recent Developments/Updates
Table 48. Ador Diagnostics Competitive Strengths & Weaknesses
Table 49. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 50. Beckman Coulter Major Business
Table 51. Beckman Coulter Point of Care Molecular Diagnostics Technology Product and Services
Table 52. Beckman Coulter Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Beckman Coulter Recent Developments/Updates
Table 54. Beckman Coulter Competitive Strengths & Weaknesses
Table 55. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 56. Becton, Dickinson and Company Major Business
Table 57. Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Product and Services
Table 58. Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Becton, Dickinson and Company Recent Developments/Updates
Table 60. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 61. Binx Health Basic Information, Manufacturing Base and Competitors
Table 62. Binx Health Major Business
Table 63. Binx Health Point of Care Molecular Diagnostics Technology Product and Services
Table 64. Binx Health Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Binx Health Recent Developments/Updates
Table 66. Binx Health Competitive Strengths & Weaknesses
Table 67. Biocartis Basic Information, Manufacturing Base and Competitors
Table 68. Biocartis Major Business
Table 69. Biocartis Point of Care Molecular Diagnostics Technology Product and Services
Table 70. Biocartis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Biocartis Recent Developments/Updates
Table 72. Biocartis Competitive Strengths & Weaknesses
Table 73. bioM?rieux Basic Information, Manufacturing Base and Competitors
Table 74. bioM?rieux Major Business
Table 75. bioM?rieux Point of Care Molecular Diagnostics Technology Product and Services
Table 76. bioM?rieux Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. bioM?rieux Recent Developments/Updates
Table 78. bioM?rieux Competitive Strengths & Weaknesses
Table 79. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 80. Bio-Rad Laboratories Major Business
Table 81. Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Product and Services
Table 82. Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Bio-Rad Laboratories Recent Developments/Updates
Table 84. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 85. Bosch Healthcare Solutions Basic Information, Manufacturing Base and Competitors
Table 86. Bosch Healthcare Solutions Major Business
Table 87. Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Product and Services
Table 88. Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Bosch Healthcare Solutions Recent Developments/Updates
Table 90. Bosch Healthcare Solutions Competitive Strengths & Weaknesses
Table 91. Curetis Basic Information, Manufacturing Base and Competitors
Table 92. Curetis Major Business
Table 93. Curetis Point of Care Molecular Diagnostics Technology Product and Services
Table 94. Curetis Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Curetis Recent Developments/Updates
Table 96. Curetis Competitive Strengths & Weaknesses
Table 97. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 98. Eurofins Scientific Major Business
Table 99. Eurofins Scientific Point of Care Molecular Diagnostics Technology Product and Services
Table 100. Eurofins Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Eurofins Scientific Recent Developments/Updates
Table 102. Eurofins Scientific Competitive Strengths & Weaknesses
Table 103. Genetic Signatures Basic Information, Manufacturing Base and Competitors
Table 104. Genetic Signatures Major Business
Table 105. Genetic Signatures Point of Care Molecular Diagnostics Technology Product and Services
Table 106. Genetic Signatures Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Genetic Signatures Recent Developments/Updates
Table 108. Genetic Signatures Competitive Strengths & Weaknesses
Table 109. Grifols Basic Information, Manufacturing Base and Competitors
Table 110. Grifols Major Business
Table 111. Grifols Point of Care Molecular Diagnostics Technology Product and Services
Table 112. Grifols Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Grifols Recent Developments/Updates
Table 114. Grifols Competitive Strengths & Weaknesses
Table 115. Hibergene Diagnostics Basic Information, Manufacturing Base and Competitors
Table 116. Hibergene Diagnostics Major Business
Table 117. Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 118. Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Hibergene Diagnostics Recent Developments/Updates
Table 120. Hibergene Diagnostics Competitive Strengths & Weaknesses
Table 121. Lumos Diagnostics Basic Information, Manufacturing Base and Competitors
Table 122. Lumos Diagnostics Major Business
Table 123. Lumos Diagnostics Point of Care Molecular Diagnostics Technology Product and Services
Table 124. Lumos Diagnostics Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Lumos Diagnostics Recent Developments/Updates
Table 126. Lumos Diagnostics Competitive Strengths & Weaknesses
Table 127. Roche Basic Information, Manufacturing Base and Competitors
Table 128. Roche Major Business
Table 129. Roche Point of Care Molecular Diagnostics Technology Product and Services
Table 130. Roche Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Roche Recent Developments/Updates
Table 132. Roche Competitive Strengths & Weaknesses
Table 133. Siemens Basic Information, Manufacturing Base and Competitors
Table 134. Siemens Major Business
Table 135. Siemens Point of Care Molecular Diagnostics Technology Product and Services
Table 136. Siemens Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Siemens Recent Developments/Updates
Table 138. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 139. Thermo Fisher Scientific Major Business
Table 140. Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Product and Services
Table 141. Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 142. Point of Care Molecular Diagnostics Technology Raw Material
Table 143. Key Manufacturers of Point of Care Molecular Diagnostics Technology Raw Materials
Table 144. Point of Care Molecular Diagnostics Technology Typical Distributors
Table 145. Point of Care Molecular Diagnostics Technology Typical Customers
LIST OF FIGURES
Figure 1. Point of Care Molecular Diagnostics Technology Picture
Figure 2. World Point of Care Molecular Diagnostics Technology Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Point of Care Molecular Diagnostics Technology Total Market Size (2017-2028) & (USD Million)
Figure 4. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Region (2017-2028)
Figure 5. United States Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 6. China Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 7. Europe Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 8. Japan Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 11. India Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 12. Point of Care Molecular Diagnostics Technology Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Point of Care Molecular Diagnostics Technology by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Point of Care Molecular Diagnostics Technology Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Point of Care Molecular Diagnostics Technology Markets in 2021
Figure 17. United States VS China: Point of Care Molecular Diagnostics Technology Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Point of Care Molecular Diagnostics Technology Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Type in 2021
Figure 20. Polymerase Chain Reaction
Figure 21. In Situ Hybridization
Figure 22. Gene Chips
Figure 23. Next Generation Sequencing
Figure 24. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Type (2017-2028)
Figure 25. World Point of Care Molecular Diagnostics Technology Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Application in 2021
Figure 27. Hospitals and Clinics
Figure 28. Independent Clinical Laboratories
Figure 29. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Point of Care Molecular Diagnostics Technology in 2021
Figure 31. Manufacturing Process Analysis of Point of Care Molecular Diagnostics Technology
Figure 32. Point of Care Molecular Diagnostics Technology Industrial Chain
Figure 33. Distribution Channel Breakdown for Point of Care Molecular Diagnostics Technology Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
Figure 1. Point of Care Molecular Diagnostics Technology Picture
Figure 2. World Point of Care Molecular Diagnostics Technology Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Point of Care Molecular Diagnostics Technology Total Market Size (2017-2028) & (USD Million)
Figure 4. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Region (2017-2028)
Figure 5. United States Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 6. China Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 7. Europe Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 8. Japan Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 11. India Point of Care Molecular Diagnostics Technology Market Size (2017-2028) & (USD Million)
Figure 12. Point of Care Molecular Diagnostics Technology Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Point of Care Molecular Diagnostics Technology by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Point of Care Molecular Diagnostics Technology Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Point of Care Molecular Diagnostics Technology Markets in 2021
Figure 17. United States VS China: Point of Care Molecular Diagnostics Technology Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Point of Care Molecular Diagnostics Technology Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Type in 2021
Figure 20. Polymerase Chain Reaction
Figure 21. In Situ Hybridization
Figure 22. Gene Chips
Figure 23. Next Generation Sequencing
Figure 24. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Type (2017-2028)
Figure 25. World Point of Care Molecular Diagnostics Technology Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Application in 2021
Figure 27. Hospitals and Clinics
Figure 28. Independent Clinical Laboratories
Figure 29. World Point of Care Molecular Diagnostics Technology Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Point of Care Molecular Diagnostics Technology in 2021
Figure 31. Manufacturing Process Analysis of Point of Care Molecular Diagnostics Technology
Figure 32. Point of Care Molecular Diagnostics Technology Industrial Chain
Figure 33. Distribution Channel Breakdown for Point of Care Molecular Diagnostics Technology Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source
